436
Participants
Start Date
December 1, 2020
Primary Completion Date
August 6, 2025
Study Completion Date
August 6, 2025
Genetic Testing for PCD or PID
Patients with high likelihood of a PID disorder or a high likelihood of PCD will initially undergo research genetic testing on a commercial approved panel for PID disorders or a panel of at least 37 PCD genes.
Unaffected Family Member Genetic Testing
Unaffected family members will undergo genetic testing if genetic findings are identified in their affected family member.
National Heart, Lung and Blood Institute, Bethesda
University of North Carolina at Chapel Hill, Chapel Hill
Washington University in St. Louis, St Louis
Children's Hospital Colorado, Aurora
Stanford University, Palo Alto
Seattle Children's Hospital, Seattle
The Hospital for Sick Children, Toronto
McGill University, Montreal
Washington University School of Medicine
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Children's Hospital Colorado
OTHER
Stanford University
OTHER
Seattle Children's Hospital
OTHER
The Hospital for Sick Children
OTHER
McGill University
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
University of North Carolina, Chapel Hill
OTHER